An observational study in Eosinophilic Gastrointestinal Disorders (EGID), Eosinophilic Esophagitis and Eosinophilic Disorder, sponsored by Children's Hospital Medical Center, Cincinnati. Completed at 8 sites in United States. Open to participants aged 1 Year to 12 Years. Per ClinicalTrials.gov, last updated 2020-09-02.
Sponsored by Children's Hospital Medical Center, Cincinnati · Observational
Among 13 studies in Eosinophilic Esophagitis by Children's Hospital Medical Center, Cincinnati — 3 open to participants now, 3 under way, none of them phase 3. Eosinophilic Esophagitis · Children's Hospital Medical Center, Cincinnati.
Among the 13 studies in Eosinophilic Esophagitis by Children's Hospital Medical Center, Cincinnati, this one is the only one that started in 2012, is one of 5 observational ones, and was the 2nd registered.
235 studies on the registry are indexed under Eosinophilic Esophagitis; 53 are open to participants now.
Browse Eosinophilic Esophagitis studies →3 of the 13 studies in Eosinophilic Esophagitis by Children's Hospital Medical Center, Cincinnati are open now, in 1 country. Recruiting first, the newest first:
Children's Hospital Medical Center, Cincinnati · Sites in United States
Ages 18–70
Children's Hospital Medical Center, Cincinnati · Sites in United States
Ages 18–59
Children's Hospital Medical Center, Cincinnati · Sites in United States
Ages 3+
By country, each count listing its studies:
Of the 42 Eosinophilic Esophagitis studies recruiting now, 12 (29%) set no upper age limit and 27 (64%) stop at 75 or younger; 27 take children under 18; 7 take healthy volunteers.
This study: 1 Year to 12 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 6 · Phase 3 2
First in 2001; this study’s year is marked. 1 started in 2012.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 34 is below the median of 88 across 85 observational studies indexed under Eosinophilic Esophagitis.
Median enrollment 20 across the 8 interventional studies, 187 across the 5 observational. Of the 10 that completed or were terminated, 5 (50%) have results posted.
This tab as a report to print or save as PDF → With an account.
Children's Hospital Medical Center, Cincinnati is the lead sponsor of 673 studies on the registry; 129 are open to participants now.
Of its 57 completed or terminated interventional studies of FDA-regulated products, 31 (54%) have results posted.
None of the studies under way reaches primary completion within a year.
Among the 13 studies in Eosinophilic Esophagitis by Children's Hospital Medical Center, Cincinnati, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Develop Registry tool
The purpose of this research study is to develop a registry tool used for the management and care of patients with eosinophilic disorders, and create a research resource that will provide further insights into these disorders.
Eosinophilic Gastrointestinal Disorders
Inclusion Criteria:
Registry Aim
The registry will allow for the standardization of care while also allowing us to identify gaps in care that need to be addressed and areas for future research at Cincinnati Children's Hospital Medical Center (CCHMC) and collaborating sites around the nation.
Time frame: Open-ended
Ran from Nov 2012 to primary completion in Dec 2016, 49 months.
Of 52 non-industry observational studies under Eosinophilic Esophagitis, half reached primary completion within 49 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 120. This study's 49 months is close to that.
Counting every sponsor, half of 55 studies reached it within 49 months; a quarter within 22 and three quarters within 120.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Children's Hospital Medical Center, Cincinnati →